Download MendeleyIdentification of a Phenylacylsulfonamide Series of Dual Bcl-2/Bcl-Xl Antagonists.
Perez, H.L., Banfi, P., Bertrand, J.A., Cai, Z.W., Grebinski, J.W., Kim, K., Lippy, J., Modugno, M., Naglich, J., Schmidt, R.J., Tebben, A., Vianello, P., Wei, D.D., Zhang, L., Galvani, A., Lombardo, L.J., Borzilleri, R.M.(2012) Bioorg Med Chem Lett 22: 3946
- PubMed: 22608961
- DOI: https://doi.org/10.1016/j.bmcl.2012.04.103
- Primary Citation of Related Structures:
4AQ3 - PubMed Abstract:
A series of phenylacylsulfonamides has been prepared as antagonists of Bcl-2/Bcl-xL. In addition to potent binding affinities for both Bcl-2 and Bcl-xL, these compounds were shown to induce classical markers of apoptosis in isolated mitochondria. Overall weak cellular potency was improved by the incorporation of polar functionality resulting in compounds with moderate antiproliferative activity.
Organizational Affiliation:
Bristol-Myers Squibb Research, PO Box 4000, Princeton, NJ 08543, USA. heidi.perez@bms.com
